About Bioject Medical Technologies
Bioject is a medical device company. The company develops, manufactures, and markets jet injection systems for needle-free drug delivery. The Company's Biojector 2000 allows healthcare professionals to inject medications through the skin without a needle. Bioject sells products directly to healthcare providers and licenses its technology to pharmaceutical and biotechnology companies.
Missing: Bioject Medical Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Bioject Medical Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Bioject Medical Technologies Patents
Bioject Medical Technologies has filed 9 patents.
Androgens and anabolic steroids, Prodrugs, Androstanes, Engine fuel system technology, Engine technology
Androgens and anabolic steroids, Prodrugs, Androstanes, Engine fuel system technology, Engine technology
Latest Bioject Medical Technologies News
Jan 25, 2021
Worldwide Needle Free Diabetes Care Industry To 2025 - Players Include Akra Dermojet, Antares Pharma & Bioject Medical Technologies Among Others DUBLIN, Jan. 25, 2021 /PRNewswire/ -- The "Needle Free Diabetes Care Market Research Report by Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, and Jet Injectors), by End User (Consumer, Diagnostic Center, and Hospitals and... Author: Jan 25, 2021 10:45 AM EST The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.1. The Global Needle Free Diabetes Care Market is expected to grow from USD 8,902.75 Million in 2020 to USD 18,086.62 Million by the end of 2025.2. The Global Needle Free Diabetes Care Market is expected to grow from EUR 7,806.10 Million in 2020 to EUR 15,858.69 Million by the end of 2025.3. The Global Needle Free Diabetes Care Market is expected to grow from GBP 6,939.64 Million in 2020 to GBP 14,098.41 Million by the end of 2025.4. The Global Needle Free Diabetes Care Market is expected to grow from JPY 950,149.56 Million in 2020 to JPY 1,930,300.75 Million by the end of 2025.5. The Global Needle Free Diabetes Care Market is expected to grow from AUD 12,927.98 Million in 2020 to AUD 26,264.17 Million by the end of 2025. Market Segmentation & Coverage:This research report categorizes the Needle Free Diabetes Care to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Device Type, the Needle Free Diabetes Care Market is examined across Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, and Jet Injectors. Based on End User, the Needle Free Diabetes Care Market is examined across Consumer, Diagnostic Center, and Hospitals and Clinic. Based on Geography, the Needle Free Diabetes Care Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Needle Free Diabetes Care Market including Akra Dermojet, Antares Pharma, Inc., Bioject Medical Technologies Inc., Echo Therapeutics Inc., European Pharma Group BV, Injex Pharma AG, MannKind Corporation, Medical International Technology, Inc., Pharmajet, Inc., and The 3M Company. Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Needle Free Diabetes Care Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth. The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments The report answers questions such as:1. What is the market size and forecast of the Global Needle Free Diabetes Care Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Needle Free Diabetes Care Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Needle Free Diabetes Care Market?4. What is the competitive strategic window for opportunities in the Global Needle Free Diabetes Care Market?5. What are the technology trends and regulatory frameworks in the Global Needle Free Diabetes Care Market?6. What are the modes and strategic moves considered suitable for entering the Global Needle Free Diabetes Care Market? Key Topics Covered: 1. Preface1.1. Objectives of the Study1.2. Market Segmentation & Coverage1.3. Years Considered for the Study1.4. Currency & Pricing1.5. Language1.6. Limitations1.7. Stakeholders 2. Research Methodology2.1. Research Process2.1.1. Define: Research Objective2.1.2. Determine: Research Design2.1.3. Prepare: Research Instrument2.1.4. Collect: Data Source2.1.5. Analyze: Data Interpretation2.1.6. Formulate: Data Verification2.1.7. Publish: Research Report2.1.8. Repeat: Report Update2.2. Research Execution2.2.1. Initiation: Research Process2.2.2. Planning: Develop Research Plan2.2.3. Execution: Conduct Research2.2.4. Verification: Finding & Analysis2.2.5. Publication: Research Report2.3. Research Outcome 3. Executive Summary3.1. Introduction3.2. Market Outlook3.3. Device Type Outlook3.4. End User Outlook3.5. Geography Outlook3.6. Competitor Outlook 4. Market Overview4.1. Introduction4.2. Cumulative Impact of COVID-194.3. Geographic Growth Opportunities 5. Market Insights5.1. Market Dynamics5.1.1. Drivers5.1.2. Restraints5.1.3. Opportunities5.1.4. Challenges5.2. Porters Five Forces Analysis5.2.1. Threat of New Entrants5.2.2. Threat of Substitutes5.2.3. Bargaining Power of Customers5.2.4. Bargaining Power of Suppliers5.2.5. Industry Rivalry 6. Global Needle Free Diabetes Care Market, By Device Type6.1. Introduction6.2. Insulin Infuser6.3. Insulin Patches6.4. Insulin Pens6.5. Insulin Pumps6.6. Jet Injectors 7. Global Needle Free Diabetes Care Market, By End User7.1. Introduction7.2. Consumer7.3. Diagnostic Center7.4. Hospitals and Clinic 8. Americas Needle Free Diabetes Care Market8.1. Introduction8.2. Argentina8.3. Brazil8.4. Canada8.5. Mexico8.6. United States 9. Asia-Pacific Needle Free Diabetes Care Market9.1. Introduction9.2. Australia9.3. China9.4. India9.5. Indonesia9.6. Japan9.7. Malaysia9.8. Philippines9.9. South Korea9.10. Thailand 10. Europe, Middle East & Africa Needle Free Diabetes Care Market10.1. Introduction10.2. France10.3. Germany10.4. Italy10.5. Netherlands10.6. Qatar10.7. Russia10.8. Saudi Arabia10.9. South Africa10.10. Spain10.11. United Arab Emirates10.12. United Kingdom 11. Competitive Landscape11.1. FPNV Positioning Matrix11.1.1. Quadrants11.1.2. Business Strategy11.1.3. Product Satisfaction11.2. Market Ranking Analysis11.3. Market Share Analysis11.4. Competitive Scenario11.4.1. Merger & Acquisition11.4.2. Agreement, Collaboration, & Partnership11.4.3. New Product Launch & Enhancement11.4.4. Investment & Funding11.4.5. Award, Recognition, & Expansion 12. Company Usability Profiles12.1. Akra Dermojet12.2. Antares Pharma, Inc.12.3. Bioject Medical Technologies Inc.12.4. Echo Therapeutics Inc.12.5. European Pharma Group BV12.6. Injex Pharma AG12.7. MannKind Corporation12.8. Medical International Technology, Inc.12.9. Pharmajet, Inc.12.10. The 3M Company 13. AppendixFor more information about this report visit https://www.researchandmarkets.com/r/4pnewo Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 View original content: http://www.prnewswire.com/news-releases/worldwide-needle-free-diabetes-care-industry-to-2025---players-include-akra-dermojet-antares-pharma--bioject-medical-technologies-among-others-301213944.html
Bioject Medical Technologies Frequently Asked Questions (FAQ)
When was Bioject Medical Technologies founded?
Bioject Medical Technologies was founded in 1985.
Where is Bioject Medical Technologies's headquarters?
Bioject Medical Technologies's headquarters is located at 7180 SW Sandburg Street, Portland.
What is Bioject Medical Technologies's latest funding round?
Bioject Medical Technologies's latest funding round is Acq - P2P.
How much did Bioject Medical Technologies raise?
Bioject Medical Technologies raised a total of $2.4M.
Who are the investors of Bioject Medical Technologies?
Investors of Bioject Medical Technologies include Inovio Pharmaceuticals, Signet Healthcare Partners, Partners for Growth and Sanders Morris Harris Private Equity.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.